In re: Walmart Inc. Securities Litigation

1:21-cv-00055

Class Action

August 29, 2025
3rd Circ. Backs Walmart In Opioid Securities Disclosure Suit

A proposed class action by Walmart investors claiming the company misled them by failing to disclose a federal opioid investigation was rejected Friday by the Third Circuit, which held the retailer's U.S. Securities and Exchange Commission filings were not false or misleading.
April 08, 2024
Walmart Beats Investor Suit Over Opioid Probe Disclosures

Walmart beat back an investor class action on Monday alleging it failed to properly disclose that it was the subject of parallel criminal and civil investigations over its opioid sales, with a Delaware federal judge ruling that the suit's challenged statements were not false or misleading.
March 23, 2021
Pomerantz, Rosen Fight In Del. To Lead Walmart Investor Suit

The Rosen Law Firm and Pomerantz LLP opened a formal U.S. District Court face-off in Delaware Monday for class lead counsel status in a consolidated securities action targeting Walmart for allegations that it misled public investors about its part in the opioid epidemic.
January 20, 2021
Walmart Hit With Investor Suit Over DOJ Opioid Crisis Probe

Walmart shareholders on Wednesday accused the retail giant of withholding details about its alleged involvement in the opioid crisis, which resulted in a U.S. Department of Justice investigation, telling a Delaware federal court that the company's stock price tanked after the controversy came to light.